Literature DB >> 27027645

Increased toxic urinary cations in males with interstitial cystitis: a possible cause of bladder symptoms.

Sulabha Argade1, Zoltan Berecz1, Yongxuan Su2, C Lowell Parsons3.   

Abstract

PURPOSE: To identify and quantify toxic urinary cations in male patients with bladder pain syndrome/interstitial cystitis versus male controls, to compare them in symptomatic patients to those significantly improved, and to evaluate cytotoxicity of these cations to cultured urothelial cells to determine whether Tamm-Horsfall protein (THP) can neutralize the cations.
METHODS: Isolation of cationic fraction (CFs) was achieved by solid phase extraction on urine specimens of 51 male patients with IC and 33 male controls. C18 reverse-phase high-performance liquid chromatography was used to profile and quantify cationic metabolites. Major CF peaks were identified by liquid chromatography-tandem mass spectrometry. HTB-4 urothelial cells were used to determine the cytotoxicity of CFs, individual metabolites, and of metabolite mixture with THP of patient versus THP of control subject.
RESULTS: CF content was significantly higher in patients compared to controls (p < 0.001). Patients had higher levels of modified nucleosides, amino acids, and their derivatives compared to controls. Cytotoxicity for control versus patient mean (SEM) percent was 1.7 (2.9) % versus 63.0 (3.7) %, respectively, (p < 0.001). Cytotoxicity of metabolites was reduced in the presence of THP of control compared to THP of patient (p < 0.001).
CONCLUSIONS: Patients with IC had significantly higher levels of cationic metabolites with higher cytotoxicity compared to controls. THP of these patients had reduced ability to sequester cytotoxicity of cationic metabolites. Patients who significantly improved on therapy had the same levels and toxicity of cationic metabolites as symptomatic males, suggesting that these cations may be the cause of epithelial dysfunction in IC.

Entities:  

Keywords:  Bladder pain syndrome; Cytotoxicity; Interstitial cystitis; Toxic urinary cations; Urinary metabolites

Mesh:

Substances:

Year:  2016        PMID: 27027645     DOI: 10.1007/s00345-016-1808-4

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  29 in total

1.  Toxic factors in human urine that injure urothelium.

Authors:  Mahadevan Rajasekaran; Paul Stein; C Lowell Parsons
Journal:  Int J Urol       Date:  2006-04       Impact factor: 3.369

2.  The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis.

Authors:  C L Parsons; M Greenberger; L Gabal; M Bidair; G Barme
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

3.  Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987.

Authors:  J Y Gillenwater; A J Wein
Journal:  J Urol       Date:  1988-07       Impact factor: 7.450

4.  Bladder surface glycosaminoglycans: an epithelial permeability barrier.

Authors:  C L Parsons; D Boychuk; S Jones; R Hurst; H Callahan
Journal:  J Urol       Date:  1990-01       Impact factor: 7.450

5.  Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis.

Authors:  C L Parsons; P C Stein; M Bidair; D Lebow
Journal:  Neurourol Urodyn       Date:  1994       Impact factor: 2.696

6.  Urine markers of interstitial cystitis.

Authors:  D R Erickson
Journal:  Urology       Date:  2001-06       Impact factor: 2.649

7.  Role of sialic acid in urinary cytoprotective activity of Tamm-Horsfall protein.

Authors:  C Lowell Parsons; Mahadevan Rajasekaran; Amir H Arsanjani; Marianne Chenoweth; Paul Stein
Journal:  Urology       Date:  2007-03       Impact factor: 2.649

8.  Tamm-Horsfall protein protects urothelial permeability barrier.

Authors:  Paul Stein; Mahadevan Rajasekaran; C Lowell Parsons
Journal:  Urology       Date:  2005-10       Impact factor: 2.649

9.  A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate.

Authors:  C L Parsons; G Benson; S J Childs; P Hanno; G R Sant; G Webster
Journal:  J Urol       Date:  1993-09       Impact factor: 7.450

10.  Defective Tamm-Horsfall protein in patients with interstitial cystitis.

Authors:  C Lowell Parsons; Paul Stein; Paul Zupkas; Marianne Chenoweth; Sulabha P Argade; Jeffrey G Proctor; Anup Datta; R Nicholas Trotter
Journal:  J Urol       Date:  2007-10-22       Impact factor: 7.450

View more
  2 in total

1.  Best of the 2016 AUA Annual Meeting: Highlights From the 2016 American Urological Association Annual Meeting, May 6-10, 2016, San Diego, CA.

Authors:  J Curtis Nickel; Michael A Gorin; Partin Alan W; Stacy Loeb; Shapiro Ellen; Michael B Chancellor; Dean G Assimos; Michael K Brawer; Benjamin M Brucker
Journal:  Rev Urol       Date:  2016

2.  In vitro cytotoxicity of human urine and its potential toxic parameters towards bladder cancer cells.

Authors:  Hongda Zhao; Ryan Tsz-Hei Tse; Carol Ka-Lo Cheng; Christine Yim-Ping Wong; Angel Wing-Yan Kong; Ronald Cheong-Kin Chan; Peter Ka-Fung Chiu; Chi-Fai Ng; Jeremy Yuen-Chun Teoh
Journal:  PLoS One       Date:  2022-10-19       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.